# Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/acaai/123890) · 2026-11-15 · Medicine
Page: https://themorning.science/story/omalizumab-linked-with-anaphylaxis-elimination-in-meat-allergy-9cee0a26e61e704e
Kind: research · Impact: medium

## In brief

- In one case series, omalizumab (Xolair) appeared to eliminate anaphylaxis risk in patients with alpha-gal syndrome who still had severe allergic reactions to red meat despite avoiding it.
- The finding comes from a case series reported in MedPage Today's coverage of an ACAAI meeting, not from a controlled trial.

## Why it matters

Alpha-gal syndrome is a meat allergy linked to tick bites, and patients who cannot control reactions by avoidance have few options. If confirmed, omalizumab could be a treatment option for these patients, but the evidence so far comes from a case series.

## Coverage

- [Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy](https://www.medpagetoday.com/meetingcoverage/acaai/123890) — MedPageToday.com - medical news for physicians, 2026-11-15

Tags: allergy, alpha-gal, omalizumab, anaphylaxis, meat-allergy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
